Introduction
The development of preimplantation mammalian embryos is controlled by specific maternal and embryonic genes, as well as by hormones and a continuing supply of energy from the mother. It is well established that insulin plays the role of a growth factor for many rapidly proliferating cells and its effects on preimplantation embryo development are of interest.
There is increasing evidence to support the involvement of insulin in the control of early embryo development. The stimulation of protein synthesis by insulin in vitro at the time of embryo compaction coincides with the appearance of insulin receptors on compacting eight-cell embryos and a switch in energy dependence from lactate and pyruvate to glucose (Gardner and Leese, 1988; Harvey and Kaye, 1991 (Diamond et al, 1989;  Beebe and Kaye, 1991 (Vercheval et al, 1990) (Veselá et al, 1993 Kaye, 1988 Kaye, , 1992 . However, insulin-receptor mRNA is not expressed until the 8-cell stage in mouse embryos (Schultz et al, 1992 ) and addition of insulin to the culture medium had no detect¬ able growth-promoting effects on two-cell embryos in vitro (Diamond et al, 1991) , excluding a direct influence of insulin on preimplantation embryos. Furthermore, blastocysts from dia¬ betic (streptozotocin-induced) rats were found to utilize glu¬ cose at a similar rate to that of normal blastocysts and insulin had no effect on glucose uptake, utilization, incorporation or turnover (Brison and Leese, 1990; Dufrasnes et al, 1993) . In addition, Gardner and Leese (1988) 
